Amanote Research

Amanote Research

    RegisterSign In

Gilteritinib Likely New Standard Care for AML

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2019-046
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

April 1, 2019

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)


Related search

Preconception Care: A New Standard of Care Within Maternal Health Services

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Teleconsultation for Left Ventricular Assist Device Patients: A New Standard of Care

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Endovascular Mechanical Thrombectomy for Acute Ischemic Stroke: A New Standard of Care

Journal of Stroke
NeurologyCardiovascular MedicineCardiology
2015English

Targeting mTOR for the Treatment of AML. New Agents and New Directions.

Oncotarget
Oncology
2011English

Data Offers New Insights Into AML

Cancer Discovery
Oncology
2018English

Standard of Care

Journal of Empirical Research on Human Research Ethics
MedicineCommunicationLawEducationSocial Psychology
2016English

New Standard for Localized UTUC

Nature Reviews Urology
Urology
2020English

Standard of Care

Medico-Legal Journal
Medicine
1982English

Thalidomide and Dexamethasone: A New Standard of Care for Initial Therapy in Multiple Myeloma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy